- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-50-0004203

Shiba Life Sciences Private Limited
About Shiba Life Sciences Private Limited
Data last updated:
Shiba Life Sciences Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2004PTC028949. Its GSTIN is 09AAKCS8019E1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Kusum Singh and Rajesh Prasad Singh.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/115 Vikas Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.11 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹24,969 (net margin 0.1%) and EBITDA of ₹6.92 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹57 Lakh on record.
Shiba Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0004203). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Shiba Life Sciences
Contact details
Shiba Life Sciences Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2/115 Vikas Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shiba Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shiba Life Sciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Shiba Life Sciences Private Limited, buy the company report.
Financials of Shiba Life Sciences Private Limited
FY 2025 filings availableShiba Life Sciences Private Limited reported revenue of ₹2.11 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 28% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,969 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shiba Life Sciences Private Limited, buy the company report.
Board of directors of Shiba Life Sciences Private Limited
Shiba Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kusum Singh Also directs: Strong Medicine Labs Private Limited | Director | 16 Apr 2007 | 19 Years 6 Months | Current |
| Rajesh Prasad Singh Also directs: Strong Medicine Labs Private Limited | Director | 26 Nov 2008 | 17 Years 10 Months | Current |
Auditor
Shiba Life Sciences Private Limited is audited by AMIT PRAKASH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT PRAKASH & CO | FY 2020 | 011106C |
Shareholding
The shareholding of Shiba Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Shiba Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Aug 2021 | 100496146 | Others | ₹4 Lakh | Open | |
| 29 Dec 2009 | 10195742 | Canara Bank | ₹53 Lakh | Open |
To see the full charge records of Shiba Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Shiba Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shiba Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shiba Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCS8019E1Z5 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shiba Life Sciences Private Limited, buy the company report.
Recent activity
Shiba Life Sciences Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Rajesh Prasad Singh ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Shiba Life Sciences is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 August 2004 (22+ years old) and is registered under CIN U24232UP2004PTC028949.
Shiba Life Sciences has 2 current directors:
- Kusum Singh - Director
- Rajesh Prasad Singh - Director
The latest financial statements of Shiba Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shiba Life Sciences is 09AAKCS8019E1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Shiba Life Sciences is U24232UP2004PTC028949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shiba Life Sciences was incorporated on 16 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Kanpur.
Rajesh Prasad Singh ceased to be Additional Director on 29 Sep 2024. Rajesh Kumar Srivastava ceased to be Director on 26 Nov 2008. Rajesh Prasad Singh was appointed as Director on 26 Nov 2008. Shiba Life Sciences has 4 board changes on record in total.
Yes, Shiba Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0004203).
The registered office of Shiba Life Sciences is at 2115 Vikas Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Shiba Life Sciences operates in the pharma industry, in the drug formulation and development segment.